UK markets close in 7 hours 44 minutes

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
515.40+0.50 (+0.10%)
As of 9:46AM CEST. Market open.
Full screen
Previous close514.90
Open513.10
Bid515.20 x 0
Ask515.30 x 0
Day's range513.10 - 518.90
52-week range400.20 - 521.90
Volume193,014
Avg. volume2,140,703
Market cap1.184T
Beta (5Y monthly)0.32
PE ratio (TTM)28.01
EPS (TTM)18.40
Earnings dateN/A
Forward dividend & yield9.10 (1.75%)
Ex-dividend date26 Mar 2021
1y target est326.96
  • Here's Why Altimmune Stock Is Surging Today
    Motley Fool

    Here's Why Altimmune Stock Is Surging Today

    Shares of Altimmune (NASDAQ: ALT), a clinical-stage biopharmaceutical company, are on the move following a positive clinical readout. Investors excited about the company's potential new weight loss drug drove the stock 23% higher as of 12:34 p.m. on Wednesday. Altimmune's weight loss drug candidate, ALT-801, is a GLP-1 receptor agonist that also activates glucagon receptors.

  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 14 June 2021 – On 7 May 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 18 billion to be executed during a 12-month period beginnin

  • The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric
    Zacks

    The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric

    The Zacks Analyst Blog Highlights: Microsoft, Nike, Novo Nordisk, Caterpillar and General Electric